| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |